(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 50.61% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.85%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Fortress Biotech's revenue in 2025 is $57,784,000.On average, 1 Wall Street analysts forecast FBIO's revenue for 2025 to be $3,048,363,053, with the lowest FBIO revenue forecast at $3,048,363,053, and the highest FBIO revenue forecast at $3,048,363,053.
In 2026, FBIO is forecast to generate $4,339,977,158 in revenue, with the lowest revenue forecast at $4,339,977,158 and the highest revenue forecast at $4,339,977,158.